We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
292 result(s) found, displaying 111 to 120
-
Prescription medicine registrationActive ingredients: upadacitinib hemihydrate.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Upadacitinib
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Medicine administration kit, percutaneous, medicated, single-use.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CONSTELLA linaclotide 290 microgram hard capsule bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CONSTELLA linaclotide 145 microgram hard capsule bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CONSTELLA linaclotide 72 microgram hard capsule bottle.
-
Prescription medicine registrationActive ingredients: upadacitinib hemihydrate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - REVOLVE - Suction system canister, single-use.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - OPTIVE Fusion - Lubricant, eye.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - OPTIVE Fusion Unit dose - Lubricant, eye.